Xeris Biopharma Holdings Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 12, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	840	404	255	150	270	-
Market Cap Growth	98.58%	58.41%	69.77%	-44.38%	-	-
Enterprise Value	962	565	382	188	266	-
Last Close Price	4.99	2.75	1.87	1.01	2.19	-
PS Ratio	4.24	2.49	1.98	1.64	7.37	-
PB Ratio	-1311.91	-17.07	-47.86	4.00	3.84	-
EV/Sales Ratio	4.93	3.48	2.97	2.05	7.26	-
Debt / Equity Ratio	-299.25	-9.17	-33.79	4.38	0.93	2.58
Asset Turnover	0.77	0.63	0.49	0.34	0.21	0.15
Inventory Turnover	0.73	0.85	0.90	1.06	1.01	1.77
Quick Ratio	1.25	1.12	1.17	2.08	1.52	4.99
Current Ratio	1.93	1.67	1.64	2.54	1.80	5.40
Return on Equity (ROE)	-	-	-324.20%	-134.83%	-190.28%	-378.20%
Return on Assets (ROA)	2.88%	-5.33%	-8.25%	-15.78%	-28.45%	-38.02%
Return on Capital Employed (ROCE)	6.30%	-12.40%	-19.40%	-30.20%	-46.80%	-62.30%
Earnings Yield	-1.38%	-10.85%	-19.18%	-52.34%	-33.59%	-
FCF Yield	0.88%	-7.49%	-15.18%	-57.18%	-26.44%	-
Buyback Yield / Dilution	-8.48%	-6.61%	-1.51%	-71.62%	-85.32%	-63.32%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.